​

Avid Bioservices (CDMO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CDMO Stock Forecast

Avid Bioservices (CDMO) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $8.00, with a high of $8.00 and a low of $8.00. This represents a -35.69% decline from the last price of $12.44.

$6 $7 $8 $9 $10 $11 $12 $13 High: $8 Avg: $8 Low: $8 Last Closed Price: $12.44

CDMO Stock Rating

Avid Bioservices stock's rating consensus is Buy, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 3 0 3 Strong Sell Sell Hold Buy Strong Buy

CDMO Forecast vs Benchmarks

TypeNameUpside
StockAvid Bioservices-35.69%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$8.00
Last Closing Price$12.44$12.44$12.44
Upside/Downside---35.69%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25-14--5
Dec, 24-34--7
Nov, 24143--8
Oct, 24141--6
Sep, 24131--5
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 30, 2024Sean DodgeRBC Capital$8.00$7.565.82%-35.69%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Sep 10, 2024RBC CapitalOutperformOutperformhold
Apr 30, 2024RBC CapitalOutperformOutperformhold
Jun 22, 2023StephensOverweightOverweighthold
Mar 14, 2023KeyBancOverweightupgrade

Financial Forecast

EPS Forecast

Apr 20 Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 20Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$-0.13$0.06$2.08$0.01------
Avg Forecast$-0.33$0.09$0.24$0.08$-0.32$-0.38$-0.11$0.18--
High Forecast$-0.35$0.09$0.23$0.08$-0.33$-0.41$-0.13$0.18--
Low Forecast$-0.32$0.10$0.25$0.08$-0.31$-0.34$-0.09$0.19--
Surprise %-60.61%-33.33%766.67%-87.50%------

Revenue Forecast

$50M $100M $150M $200M $250M $300M Apr 20 Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 20Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$59.70M$95.87M$119.60M$149.27M------
Avg Forecast$55.63M$89.88M$117.33M$148.36M$139.09M$163.11M$190.47M$224.88M$254.90M$282.94M
High Forecast$54.51M$88.06M$114.96M$145.63M$136.53M$160.10M$186.96M$216.82M$250.20M$277.73M
Low Forecast$57.74M$93.29M$121.78M$154.09M$144.45M$169.40M$197.82M$232.94M$264.73M$293.85M
Surprise %7.31%6.66%1.93%0.61%------

Net Income Forecast

$-50M $-10M $30M $70M $110M $150M Apr 20 Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 20Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$-7.26M$11.21M$127.67M$560.00K------
Avg Forecast$-3.67M$9.20M$15.01M$5.06M$-11.45M$-23.60M$-7.16M$11.52M--
High Forecast$-4.58M$4.40M$14.61M$4.93M$-13.74M$-25.67M$-8.36M$11.10M--
Low Forecast$-2.75M$14.01M$15.75M$5.31M$-9.16M$-21.53M$-5.97M$11.95M--
Surprise %97.84%21.85%750.59%-88.92%------

CDMO Forecast FAQ

Is Avid Bioservices stock a buy?

Avid Bioservices stock has a consensus rating of Buy, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Avid Bioservices is a favorable investment for most analysts.

What is Avid Bioservices's price target?

Avid Bioservices's price target, set by 3 Wall Street analysts, averages $8 over the next 12 months. The price target range spans from $8 at the low end to $8 at the high end, suggesting a potential -35.69% change from the previous close price of $12.44.

How does Avid Bioservices stock forecast compare to the average forecast of its sector, industry, and investment themes?

Avid Bioservices stock forecast shows a -35.69% downside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for Avid Bioservices over the past three months?

  • January 2025: 0% Strong Buy, 20.00% Buy, 80.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 42.86% Buy, 57.14% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 12.50% Strong Buy, 50.00% Buy, 37.50% Hold, 0% Sell, 0% Strong Sell.

What is Avid Bioservices’s EPS forecast?

Avid Bioservices's average annual EPS forecast for its fiscal year ending in April is -0.32 for 2024, a -3300.00% decrease from the reported $0.01 in 2023. The prediction for 2025 is $-0.38, $-0.11 for 2026, $0.18 for 2027, $0 for 2028, and $0 for 2029.

What is Avid Bioservices’s revenue forecast?

Avid Bioservices's average annual revenue forecast for its fiscal year ending in April is $139.09M for 2024, a -6.82% decrease from the reported $149.27M in 2023. The forecast for 2025 is $163.11M, $190.47M for 2026, $224.88M for 2027, $254.9M for 2028, and $282.94M for 2029.

What is Avid Bioservices’s net income forecast?

For its fiscal year ending in April, Avid Bioservices's average annual net income forecast is $-11.45M for 2024, reflecting a -2144.64% decrease from the reported $560K in 2023. The projection for 2025 is $-23.602M, $-7.162M for 2026, $11.52M for 2027, $0 for 2028, and $0 for 2029.